Page last updated: 2024-10-25

amphetamine and Asthenia

amphetamine has been researched along with Asthenia in 2 studies

Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.

Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PISANI, D1
CANGI, G1
Potter, PJ1

Other Studies

2 other studies available for amphetamine and Asthenia

ArticleYear
[Phenylaminopropane in asthenic states of convalescence].
    Rassegna internazionale di clinica e terapia, 1950, Jul-31, Volume: 30, Issue:14

    Topics: Amphetamine; Asthenia; Convalescence; Humans; Phenylpropanolamine

1950
Asthenia and paralysis.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1998, Nov-17, Volume: 159, Issue:10

    Topics: Amphetamine; Asthenia; Central Nervous System Stimulants; Humans; Megestrol; Neoplasms; Paralysis; P

1998